Septerna is about to find out how a biotech without “any meaningful clinical data” fares in the late 2024 IPO market. | ...

The healthcare sector roughly accounts for an eighth share of the S&P 500 but lagged last year, with investors flocking to mega-cap tech and growth stocks based on the artificial intelligence (AI) ...

Jefferies analyst Peter Welford maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £114.00.

The theme for World Breast Cancer Day in 2024 is "No one should face breast cancer alone." This theme emphasises the critical ...

The WHO has recommended a single shot of RSV vaccine for pregnant women, in the third trimester that typically starts at 28 weeks, to protect their babies.

The solution will use Owkin's data network and artificial intelligence to prescreen for gBRCA mutations in breast cancer directly from digital pathology slides.

Bill Gates visiting TerraPower Isotopes, the subsidiary of the nuclear power company TerraPower that he helped found. Gates ...

Santa Barbara, Calif.– 2024 October 2 –Rupa Dainer, MD, U.S. Navy veteran and medical director, senior patient safety physician of ...

Beyonce’s father, Mathew Knowles, is sharing the details of his breast cancer journey to help raise awareness about the early ...

Ever wondered what one of the world’s top oncology leaders believe to be the next big thing in cancer care? Find out in our interview AstraZeneca's Dr Sunil Verma.

Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...

Bank of America Securities analyst Sachin Jain has reiterated their bullish stance on AZN stock, giving a Buy rating on September 30. Sachin ...